COVID-19 vaccine launched in Europe

The European Union has begun to administer the COVID-19 vaccine developed by BioNTech and Pfizer to its 446 million citizens.

COVID-19 vaccine launched in Europe
Colin Kerr
Colin Kerr
Published: Sunday, December 27, 2020
The European Union has begun to administer the COVID-19 vaccine developed by BioNTech and Pfizer to its 446 million citizens. The vaccine was intended to be officially rolled out on Sunday December 27 but on Saturday December 26 Germany, Hungary and Slovakia began giving out their first coronavirus vaccine shots in advance of the European Union’s campaign for a coordinated rollout Sunday across the union's 27 nations. European Commission President Ursula von der Leyen said on Saturday that the Pfizer-BioNTech vaccine had been delivered to all 27 member states. "Today, we start turning the page on a difficult year. The #COVID19 vaccine has been delivered to all EU countries. Vaccination will begin tomorrow across the EU," Ms von der Leyen said in a tweet. "The #EUvaccinationdays are a touching moment of unity. Vaccination is the lasting way out of the pandemic," said Ms von der Leyen. The European Centre for Disease Prevention and Control (ECDC) has stated that in the initial phases of the vaccine deployment, it is expected that demand will exceed supply. "It will be important to manage expectations through appropriate communication regarding the choices of vaccine strategies. It will also be important to consider groups or settings that may have a disproportionate risk of exposure," said an ECDC spokesperson. "Given the many unknowns in relation to COVID-19 vaccines’ characteristics, deployment, supply, and uptake, non-pharmaceutical interventions should continue to be applied, as recommended by public health authorities, following the introduction of COVID-19 vaccination. Vaccination strategies will need to be adaptable over time to unfolding events taking into account the emerging evidence. ECDC will continue to monitor factors like COVID-19 vaccine effectiveness, confidence, uptake, supply, deployment, and future emerging variants that could have an impact on the response to COVID-19 vaccines," said the spokesperson. https://www.ecdc.europa.eu/en/news-events/ecdc-releases-vaccination-rollout-strategies-eueea
Latest Articles
Organising for Success

Professional and personal goals drive practice ownership and operational choices.

Read more...

Update on Astigmatism Analysis

Read more...

Is Frugal Innovation Possible in Ophthalmology?

Improving access through financially and environmentally sustainable innovation.

Read more...

From Concept to Clinic

Partnerships with academia and industry promote innovation.

Read more...

Making IOLs a More Personal Choice

Surgeons may prefer some IOLs for their patients, but what about for themselves?

Read more...

Need to Know: Higher-Order Aberrations and Polynomials

This first instalment in a tutorial series will discuss more on the measurement and clinical implications of HOAs.

Read more...

Never Go In Blind

Novel ophthalmic block simulator promises higher rates of confidence and competence in trainees.

Read more...

Simulators Benefit Surgeons and Patients

Helping young surgeons build confidence and expertise.

Read more...

How Many Surgeries Equal Surgical Proficiency?

Internet, labs, simulators, and assisting surgery all contribute.

Read more...

Improving Clinical Management for nAMD and DME

Global survey data identify barriers and opportunities.

Read more...